跳至主要内容
临床试验/ISRCTN05245917
ISRCTN05245917已完成未知

Effects of highly specialized rehabilitation of patients with multiple sclerosis: a randomized controlled trial of personalized, targeted and multidisciplinary interventions

The Danish Sclerosis Hospitals (Denmark)0 个研究点目标入组 400 人开始时间: 2012年6月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
400

研究概览

简要总结

2012 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/22954027 protocol 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/31687884/ (added 27/09/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •Study participants will be recruited among all patients who are referred to the 4-week individual rehabilitation program during March 2012 to June 2013. Patients who are referred for a shorter rehabilitation program or theme courses are not eligible for the study.
  • •Participants must meet the following inclusion criteria:
  • •1. Aged between 18 and 65 years
  • •2. Diagnosis of multiple sclerosis (MS): relapsing remitting, primary or secondary progressive MS
  • •3. Expanded Disability Status Scale (EDSS) score = 7.5
  • •4. Can use a PC or have support/relative who can
  • •5. Ability to read and understand sufficient Danish to understand instructions both orally and in writing, and having completed a consent form

排除标准

  • •1. MS disease duration less than 6 months (the period from diagnosis to referral)
  • •2. Experienced relapse within 3 months before the neurological appraisal
  • •3. Recipient of sclerosis-specific hospital-based rehabilitation within the last 6 months
  • •4. Cognition score, Kurtzke's Functional Systems (KFS) > 2 or cognitive limitations which hinder completion of self-reported questionnaires and/or giving informed consent
  • •5. Moderate to severe depression; severe heart or lung disease
  • •6. Drug or alcohol abuse
  • •7. Any other illness that can impede participation in the study
  • •If participants develop a disease that might impair their participation in the study they will be excluded from the study at that time.

研究者

发起方
The Danish Sclerosis Hospitals (Denmark)

相似试验